Staphylococcus aureus Colonization in Community-Dwelling People With Spinal Cord Dysfunction

Archives of Physical Medicine and Rehabilitation

Volumn 88, Issue 8, 2007, Pages 979-983

  Roghmann, Mary Claire ^a,b   Gorman, Peter H ^b   Wallin, Mitchell T ^c   Kreisel, Kristen ^b   Shurland, Simone ^b   Johnson, Judith A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cross sectional studies; Fluoroquinolones; Multiple sclerosis; Rehabilitation; Spinal cord injuries; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE SCLEROSIS; NOSE MUCOSA; PERINEUM INJURY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; SPINAL CORD INJURY; SPINAL CORD LESION; STAPHYLOCOCCUS AUREUS;

COLONY COUNT, MICROBIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERINEUM; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SPINAL CORD DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 34547173180     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2007.05.005     Document Type: Article

References (29)

1. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., and Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 187 (2003) 1452-1459
2. Montgomerie J.Z. Infections in patients with spinal cord injuries. Clin Infect Dis 25 (1997) 1285-1290
3. Wertheim H.F., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 (2005) 751-762
4. Wertheim H.F., Vos M.C., Ott A., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364 (2004) 703-705
5. Yu V.L., Goetz A., Wagener M., et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315 (1986) 91-96
6. Perl T.M., Cullen J.J., Wenzel R.P., et al. Mupirocin and the Risk of Staphylococcus Aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
7. Peacock S.J., de Silva I., and Lowy F.D. What determines nasal carriage of Staphylococcus aureus?. Trends Microbiol 9 (2001) 605-610
8. Ridley M. Perineal carriage of Staph aureus. Br Med J 1 5117 (1959) 270-273
9. Squier C., Rihs J.D., Risa K.J., et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 23 (2002) 495-501
10. Olona-Cabases M., Tico-Falguera N., Ramirez-Garceran L., Del Valle-Ortiz O., Castello-Verdu T., and Garcia-Fernandez L. Methicillin-resistant Staphylococcus aureus: a four-year experience in a spinal cord injury unit in Spain. Spinal Cord 34 (1996) 315-319
11. Maeder K., Ginunas V.J., Montgomerie J.Z., and Canawati H.N. Methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with spinal cord injury. Paraplegia 31 (1993) 639-644
12. Aeilts G.D., Sapico F.L., Canawati H.N., Malik G.M., and Montgomerie J.Z. Methicillin-resistant-Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol 16 (1982) 218-223
13. Roghmann M.C., Wallin M.T., Gorman P.H., and Johnson J.A. Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Arch Phys Med Rehabil 87 (2006) 1305-1309
14. Multiple Sclerosis Council for Clinical Practice Guidelines. Urinary dysfunction and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis (1999), Paralyzed Veterans of America, Washington (DC) 1-16
15. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
16. Kurtzke J.F. Clinical definition for multiple sclerosis treatment trials. Ann Neurol 36 Suppl (1994) S73-S79
17. American Spinal Injury Association. International standards for neurological classification of SCI (2002), ASIA, Atlanta
18. Jones E.M., Bowker K.E., Cooke R., Marshall R.J., Reeves D.S., and MacGowan A.P. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect 35 (1997) 59-62
19. VandenBergh M.F., Yzerman E.P., van Belkum A., Boelens H.A., Sijmons M., and Verbrugh H.A. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 37 (1999) 3133-3140
20. Hugenholtz P., Goebel B.M., and Pace N.R. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180 (1998) 4765-4774
21. Harmsen D., Claus H., Witte W., Rothganger J., Turnwald D., and Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41 (2003) 5442-5448
22. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., and Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
23. Blumberg H.M., Rimland D., Carroll D.J., Terry P., and Wachsmuth I.K. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 163 (1991) 1279-1285
24. Bisognano C., Vaudaux P., Rohner P., Lew D.P., and Hooper D.C. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 44 (2000) 1428-1437
25. Dziekan G., Hahn A., Thune K., et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 46 (2000) 263-270
26. Salgado C.D., and Farr B.M. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures?. Infect Control Hosp Epidemiol 27 (2006) 116-121
27. Siegel J.D., Rhinehart E., Jackson M., Chiarello L., and Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings (2006). http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf Available at: URL: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed April 17, 2007.
28. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997) 505-520
29. Eriksen N.H., Espersen F., Rosdahl V.T., and Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 115 (1995) 51-60